Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax ® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. EBS today announced that it has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract with a maximum value up to $235.8 million to supply BioThrax® (Anthrax Vaccine Adsorbed) for use by all…#gaithersburg #biothrax #paulwilliams #linkedin
Source: Reuters: Health - Category: Consumer Health News Source Type: news